The CleanPlex® Comprehensive Neuromuscular Disorders Panel is a pre-designed and made-to-order multiplex PCR / amplicon-based targeted sequencing (NGS) assay designed to examine the germline variants or mutations across 132 genes associated with Comprehensive Neuromuscular Disorders. The panel targets all the exonic regions of those genes and the flanking intronic sequences. Compatible with just 10 ng of DNA, sequencing-ready libraries can be prepared using a streamlined workflow in just 3 hours. The pre-designed panel is optimized in silico to deliver data with high on-target performance and high coverage uniformity to ensure efficient use of sequencing reads.
This product is made to order. Once we receive your order, we will synthesize the panel and the kit will contain CleanPlex Multiplex PCR Primers and CleanPlex Targeted Library Kit. CleanPlex Indexed PCR Primers and CleanMag® Magnetic Beads can be ordered separately to complete the workflow from input DNA to sequencing-ready NGS libraries.
Store at -20 °C.
For Research Use Only. Not for use in diagnostic procedures.
ACTA1, AGL, AMPD1, ANO5, ATP2A1, B3GALNT2, B4GAT1, BAG3, BICD2, BIN1, BSCL2, BVES, CACNA1S, CAPN3, CAV3, CAVIN1, CCDC78, CFL2, CHAT, CHKB, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, CLCN1, CNTN1, COL12A1, COL6A1, COL6A2, COL6A3, COLQ, CRPPA, CRYAB, DAG1, DES, DMD, DNAJB6, DNM2, DOK7, DPM1, DPM2, DPM3, DYNC1H1, DYSF, EMD, FHL1, FKRP, FKTN, FLNC, GAA, GBE1, GLE1, GMPPB, GNE, HNRNPDL, IGHMBP2, ISPD, ITGA7, KBTBD13, KLHL40, KLHL41, LAMA2, LAMP2, LARGE1, LDB3, LIMS2, LMNA, LMOD3, MATR3, MEGF10, MICU1, MTM1, MTMR14, MUSK, MYH2, MYH7, MYOT, NEB, PABPN1, PFKM, PHKA1, PLEC, PLEKHG5, PMM2, PNPLA2, POLG, POLG2, POMGNT1, POMGNT2, POMK, POMT1, POMT2, PYGM, RAPSN, RRM2B, RXYLT1, RYR1, SCN4A, SELENON, SGCA, SGCB, SGCD, SGCE, SGCG, SIL1, SMCHD1, SPEG, STAC3, SUCLA2, SYNE1, SYNE2, TCAP, TIA1, TK2, TMEM43, TNNI2, TNNT1, TNPO3, TOR1AIP1, TPM2, TPM3, TRAPPC11, TRIM32, TRIP4, TRPV4, TTN, TWNK, TYMP, UBA1, VCP, VRK1
Gonzalez-Quereda, L. et al. Two different NGS approaches to address molecular diagnosis of congenital neuromuscular diseases. Neuromuscular Disorders. 2017; 27(2):S197.
Teoh HL, et al. Approaches to genetic diagnosis in neuromuscular conditions in the era of next generation sequencing. Journal of Neurology, Neurosurgery & Psychiatry 2016;87:1384-1385.